Tvardi Therapeutics (TVRD) Other Non-Current Assets (2015 - 2026)

Tvardi Therapeutics (TVRD) posted Other Non-Current Assets of $17000.0 for Q1 2026, little changed sequentially from $17000.0 in Q4 2025.

Tvardi Therapeutics (TVRD) Other Non-Current Assets (2015 - 2026) Analysis & Trends

Tvardi Therapeutics has reported Other Non-Current Assets for 12 years, with the latest figure at $17000.0 in Q1 2026.

Quarterly Other Non-Current Assets changed N/A year-over-year to $17000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17000.0 (changed N/A YoY) and the FY2025 annual result came in at $17000.0, changed 0.0% from the prior year.
Other Non-Current Assets steadied at $17000.0 in Q1 2026 per TVRD's latest filing, from $17000.0 in the prior quarter.
Over five years, Other Non-Current Assets peaked at $1.5 million in Q2 2023 and troughed at $17000.0 in Q4 2024.
A 5-year average of $677615.4 and a median of $408000.0 in 2022 frame the typical range for Other Non-Current Assets.
The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets surged 267.65% in 2023, then plunged 98.87% in 2024.
Over 5 years, Other Non-Current Assets stood at $408000.0 in 2022, then soared by 267.65% to $1.5 million in 2023, then slumped by 98.87% to $17000.0 in 2024, then changed by 0.0% to $17000.0 in 2025, then changed by 0.0% to $17000.0 in 2026.
According to Business Quant data, Other Non-Current Assets over the past three periods registered $17000.0, $17000.0, and $17000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	1.25 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	2.31 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	124.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	618.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	109.58 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	65.13 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	202.31 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	104.44 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	62.96 Mn
10	Tvardi Therapeutics	17.36 Mn	17.36 Mn	-	17,000.00

Download Data